Who is sponsoring NCT05251597?

NCT05251597 is sponsored by Istanbul Medeniyet University.

What drugs are being tested in NCT05251597?

Interventions in NCT05251597: green exercise with aerobic exercise.

What condition does NCT05251597 study?

NCT05251597 studies Metabolic Syndrome.

Is NCT05251597 still recruiting?

NCT05251597 is currently status unknown. Last updated 29 March 2022.

Last reviewed 2022-03-29 · How we verify

NCT05251597

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison of the Effects of Green Exercise Programs on Metabolic Syndrome Parameters in Elderly Individuals

Status unknown NA Last updated 29 March 2022

What this trial tests

NA trial testing green exercise with aerobic exercise in Metabolic Syndrome in 120 participants. Status unknown.

Timeline

27 March 2022

Primary endpoint
8 October 2022

12 November 2022

Quick facts

Lead sponsor	Istanbul Medeniyet University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	120
Start date	27 March 2022
Primary completion	8 October 2022
Estimated completion	12 November 2022
Sites	2 locations across Turkey (Türkiye)

Drugs / interventions tested

green exercise with aerobic exercise

Conditions studied

Metabolic Syndrome — all drugs for Metabolic Syndrome →

Sponsor

Istanbul Medeniyet University

Who can join

Adults 65 to 85, any sex, with Metabolic Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to compare the effects of exercise programs that only aerobic exercise and combination aerobic exercise and resistance exercises on the metabolic syndrome parameters in the green exercise concept.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The Effect of Exercise on Spexin and Follistatin in Elderly Individuals.
Ayaz EY, Dincer B, Cinbaz G, Karacan E, et al · · 2025 · cited 3× · PMID 39895162 · DOI 10.1002/jcsm.13692

Verify or expand the search:

Other recruiting trials for Metabolic Syndrome

Currently open trials in the same condition.

NCT07501858 — Assessing the Association Between H. Pylori Persistence and the Severity of Insulin Resistance in Patients With Metaboli · recruiting
NCT06857929 — "Improving Health and Reducing Chronic Disease Risk in Middle-Aged Adults Through Nutrition" · NA · recruiting
NCT07237750 — iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) vs Optimized Lifestyle Intervention for Weight Loss · NA · recruiting
NCT07406191 — WB-EMS Effects on Cardiometabolic Risk Factors · NA · recruiting
NCT07383220 — Effect of Electrical Stimulation and Exercise on Blood Flow in Patients With Resistant High Blood Pressure · NA · recruiting

Other Istanbul Medeniyet University trials

Trials by the same sponsor.

NCT07478380 — Transcutaneous pO₂ Monitoring in PICU · recruiting
NCT07368244 — Turkish Translation and Content Validity of the Nottwil Environmental Factors Inventory (NEFI) in Persons With Spinal Co · recruiting
NCT07179731 — Comparison of the Effects of External Oblique Intercostal Plane Block, Subcostal Transverse Abdominis Plane Block, and T · NA · not yet recruiting
NCT07241455 — Validity of the Children's Chelsea Critical Care Physical Assessment Tool (cCPAx-TR) in Turkish Pediatric Intensive Care · completed
NCT07426497 — Osteopathic Manual Therapy vs Ganglion Impar Block for Chronic Coccydynia · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05251597 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Istanbul Medeniyet University
Last refreshed: 29 March 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05251597.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing